| | |||||
| gout | |||||
| BERITA | |||||
| Shanton Pharma Completes EOP2 Meeting with US FDA for Refractory Gout Program SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., ...
| |||||
| Anda menerima email ini karena Anda telah berlangganan Google Alerts. |
Terima notifikasi ini dalam bentuk feed RSS |
| Kirimkan Masukan |
Tidak ada komentar:
Posting Komentar